Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIP-Seq Data of purified hepatocytes

ABSTRACT: ChIP-Seq Data of purified hepatocytes

PROVIDER: PRJNA1002232 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

ChREBP ChIP-seq data from primary cultured hepatocytes

Project description:ChREBP ChIP-seq data from primary cultured hepatocytes

| PRJNA1054069 | ENA

Expression data from purified hepatoblasts and differentiated hepatocytes and cholangiocytes

Project description:Expression data from purified hepatoblasts and differentiated hepatocytes and cholangiocytes

| PRJNA472783 | ENA

Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alpha

Project description:Estrogen Receptor alpha (ERα) is a key driver of most breast cancers, and it is the target of endocrine therapies used in the clinic to treat women with ERα positive (ER+) breast cancer. The two methods ChIP-seq (chromatin immunoprecipitation coupled with deep sequencing) and RIME (Rapid Immunoprecipitation of Endogenous Proteins) have greatly improved our understanding of ERα function during breast cancer progression and in response to anti-estrogens. A critical component of both ChIP-seq and RIME protocols is the antibody that is used to pull down the bait protein. To date, most of the ChIP-seq and RIME experiments for the study of ERα have been performed using the sc-543 antibody from Santa Cruz Biotechnology. However, this antibody has been discontinued, thereby severely impacting the study of ERα in normal physiology as well as diseases such as breast cancer and ovarian cancer. Here, we compare the sc-543 antibody with other commercially available antibodies, and we show that 06-935 (EMD Millipore) and ab3575 (Abcam) antibodies can successfully replace the sc-543 antibody for ChIP-seq and RIME experiments.

2019-03-21 | PXD012930 | Pride

POLK ChIP-seq data

Project description:POLK ChIP-seq data

| PRJNA911577 | ENA

ChREBP ChIP-seq data from primary cultured hepatocytes

Project description:Identification by Chromatin immunoprecipitation DNA-sequencing (ChIP-seq) of ChREBP binding sites in primary cultured mouse hepatocytes cultured for 24h with 25 mM glucose and 100 nM insulin.

2024-01-23 | GSE250437 | GEO

ChIP-Seq Data of purified hepatocytes

Project description:Oncogenic mutations accumulating in many chromatin-associated proteins have been identified in different tumor types. With a mutation rate from 10 to 57%, ARID1A has been widely considered a tumor suppressor gene. However, whether this role is mainly due to its transcriptional-related activities or its ability to preserve genome integrity is still a matter of intense debate. Here, we show that ARID1A is largely dispensable for preserving enhancer-dependent transcriptional regulation, being ARID1B sufficient and required to compensate for ARID1A loss. We provide in vivo evidence that ARID1A is mainly required to preserve genomic integrity in adult tissues. ARID1A loss primarily results in DNA damage accumulation, interferon type I response activation, and chronic inflammation leading to tumor formation. Our data suggest that in healthy tissues, the increased genomic instability that follows ARID1A mutations and the selective pressure imposed by the microenvironment might result in the emergence of aggressive, possibly immune-resistant, tumors.

2024-03-17 | GSE240065 | GEO

ChIP-seq data for Glioma

Project description:ChIP-seq data for Glioma

| PRJNA705208 | ENA

modENCODE_White Lab: genome-wide ChIP-chip and ChIP-Seq data

Project description:modENCODE_White Lab: genome-wide ChIP-chip and ChIP-Seq data

| PRJNA131759 | ENA

ChIP-Seq on ESR1 in human liver tissue and hepatocytes

Project description:ChIP-Seq on ESR1 in human liver tissue and hepatocytes

| PRJNA666708 | ENA

AHR ChIP-seq in primary human hepatocytes treated with TCDD

Project description:AHR ChIP-seq in primary human hepatocytes treated with TCDD